Press "Enter" to skip to content

Closing Bell: Market ends marginally lower amid volatility; FMCG gains, realty, PSU Bank drag – Moneycontrol

May 18, 2022 / 04:02 PM IST

Gaurav Ratnaparkhi, Head of Technical Research, Sharekhan by BNP Paribas:

The Nifty opened on a positive note & attempted to continue with the positive momentum. On the higher side, however, it stumbled near 16400 where it attracted some profit booking. The internal structure of the recent rise shows that today’s negative close is a minor pause & the short term pullback is still intact. 

The index is expected to witness fresh buying support near 16200. Thus, this minor degree dip can be taken as a fresh buying opportunity from short term trading perspective. 

On the higher side, the short term target is pegged at 16500. The level of 16000 will act as a support for the short term.

May 18, 2022 / 03:59 PM IST

Rupak De, Senior Technical Analyst at LKP Securities:

Nifty found resistance at the crucial resistance at 16400 and slipped below before closing with a marginal loss. On the daily chart, the index remained well below the short-term moving average. The daily RSI is in the bullish crossover. 

The trend is likely to remain sideward over the near term. The resistance on the higher end is placed at 16400. On the lower end, support is visible at 16000.

May 18, 2022 / 03:52 PM IST

Shrikant Chouhan, Head of Equity Research (Retail), Kotak Securities:

The sharp rally in the previous session failed to add fizz in today’s trades, as the market did not capitalise on the firm start and rather turned range-bound to end marginally lower. 

The rampant FII selling has been weighing on investors’ minds, and worries about subdued growth going ahead due to rising interest rates is hurting the sentiment. 

On daily charts, the Nifty has formed a small bearish hammer kind of candlestick formation, which indicates a range bound activity in the near future. 

For day traders, 16200-16150 levels would act as key support zones. Above the same, the index could move up to 16400-16450. On the flip side, below 16150, uptrends could be vulnerable and could retest the level of 16050-16000.

May 18, 2022 / 03:44 PM IST

Vinod Nair, Head of Research at Geojit Financial Services:

With the support from Pharma and FMCG stocks, the domestic market had a steady run until the weak opening of the European market. UK’s soaring retail inflation number along with Fed Chair’s reassurance on bringing down the inflation, disturbed the sentiment, risking sharper rate hikes. 

With prospects of a sizeable interest rate hike by the global central banks, investors are advised to allocate higher weightage to sectors that are least affected by such policies like defensives.

May 18, 2022 / 03:35 PM IST

Rupee Close:

Indian rupee ended flat at 77.58 per dollar against Tuesday’s close of 77.56.

May 18, 2022 / 03:34 PM IST

Market Close: Indian benchmark indices ended with marginal losses in the volatile session on May 18.

At close, the Sensex was down 109.94 points or 0.20% at 54,208.53, and the Nifty was down 19 points or 0.12% at 16,240.30. About 1865 shares have advanced, 1409 shares declined, and 108 shares are unchanged.

Tata Consumer Products, Shree Cements, UltraTech Cement, Cipla and HUL were among the top Nifty gainers. However, losers were Power Grid Corporation, BPCL, Apollo Hospitals, Tata Motors and Tech Mahindra.

Among sectors, buying was seen in the FMCG and Pharma, while selling was seen in the bank, capital goods, realty, IT, metal, PSU Bank, and oil & gas indices.

BSE midcap index ended on flat note, while smallcap index was up 0.3 percent.

May 18, 2022 / 03:27 PM IST

Trident board to consider fundraising on May 30

The board meeting of Trident will be held on May 30, 2022, to consider and approve the standalone and consolidated audited financial results of the company for the quarter and financial year ended March 31, 2022.

Further, the board shall also consider raising of funds by non-convertible debt instruments along with warrants, convertible securities other than warrants or foreign currency convertible bonds and I or such other securities including Non-Convertible Debentures.

Trident was quoting at Rs 49.45, up Rs 0.30, or 0.61 percent on the BSE.

May 18, 2022 / 03:24 PM IST

Nifty PSU Bank index fell 1 percent dragged by the Canara Bank, Bank of Baroda, SBI

May 18, 2022 / 03:19 PM IST

Aditya Birla Fashion & Retail Q4 earnings:

Aditya Birla Fashion & Retail has posted consolidated net profit at Rs 43.59 crore in the quarter ended March 2022 versus loss of Rs 137.6 crore in the same quarter last fiscal.

Revenue was up 25.3% at Rs 2,283 crore versus Rs 1,821.6 crore, YoY.

Aditya Birla Fashion & Retail was quoting at Rs 281.15, up Rs 1.15, or 0.41 percent.

May 18, 2022 / 03:16 PM IST

Geojit View on Tech MahindraWe remain positive on Tech Mahindra’s business outlook on the back of strong new deal wins, deal pipeline and capabilities in new tech. we expect the margin pressure led by supply side issues to subside in the coming quarters, supported by the higher fresher intakes. We foresee earnings to grow at a healthy 13% CAGR over FY22-24E and reiterate our buy rating on the stock with a revised target price of Rs 1,372 using a target multiple of 17x P/E on FY24E Adjusted EPS.

Geojit View on Tech Mahindra     We remain positive on Tech Mahindra’s business outlook on the back of strong new deal wins, deal pipeline and capabilities in new tech. we expect the margin pressure led by supply side issues to subside in the coming quarters, supported by the higher fresher intakes.     We foresee earnings to grow at a healthy 13% CAGR over FY22-24E and reiterate our buy rating on the stock with a revised target price of Rs 1,372 using a target multiple of 17x P/E on FY24E Adjusted EPS.

May 18, 2022 / 03:10 PM IST

Sun Pharma to launch oral drug, Bempedoic Acid, in IndiaSun Pharmaceutical Industries today announced that one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India for reducing low-density lipoprotein (LDL) cholesterol. The company will launch the drug under the brand name “Brillo”, company said in its press release.

Sun Pharma to launch oral drug, Bempedoic Acid, in India     Sun Pharmaceutical Industries today announced that one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India for reducing low-density lipoprotein (LDL) cholesterol. The company will launch the drug under the brand name “Brillo”, company said in its press release.

May 18, 2022 / 03:08 PM IST

Nifty FMCG index rose 1 percent supported by the Marico, Tata Consumer Products, Hindustan Unilever

Nifty FMCG index rose 1 percent supported by the Marico, Tata Consumer Products, Hindustan Unilever